EXTR FINAL DEADLINE ALERT: A Securities Fraud Lawsuit was Filed against Extreme Networks, Inc.; Investors are Urged to Contact BFA Law before October 15 Court Deadline (Nasdaq:EXTR)

NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Extreme Networks, Inc. (NASDAQ: EXTR) and certain of the Company’s senior executives. If you invested in Extreme, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/extreme-networks-inc. Investors have until […]

ARDX DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important October 15 Deadline in Securities Class Action – ARDX

NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ardelyx, Inc. (NASDAQ: ARDX) between October 31, 2023 and July 1, 2024, both dates inclusive (the “Class Period”), of the important October 15, 2024 lead plaintiff deadline. SO WHAT: If you purchased

Visa Inc. Announcement: If You Have Suffered Losses in Visa Inc. (NYSE: V), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) — Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Visa Inc. (NYSE: V) resulting from allegations that Visa may have issued materially misleading business information to the investing public. So What: If you purchased Visa

Joint Stock Company Kaspi.kz Announcement: If You Have Suffered Losses in Joint Stock Company Kaspi.kz (NASDAQ: KSPI), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) — Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Joint Stock Company Kaspi.kz (NASDAQ: KSPI) resulting from allegations that Kaspi.kz may have issued materially misleading business information to the investing public. So What: If you

SMCI SHAREHOLDER ALERT: A Securities Fraud Lawsuit was Filed against Super Micro Computer; Investors are Urged to Contact BFA Law before October 29 Court Deadline (Nasdaq:SMCI)

NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Super Micro Computer, Inc. (NASDAQ: SMCI) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Super Micro Computer, you are

DXCM SHAREHOLDER ALERT: A Securities Fraud Lawsuit was Filed against DexCom, Inc.; Investors are Urged to Contact BFA Law before October 21 Court Deadline (Nasdaq:DXCM)

NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ: DXCM) and certain of the Company’s senior executives. If you invested in DexCom, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/dexcom-inc. Investors have until October

ELAN SHAREHOLDER ALERT: A Securities Fraud Lawsuit was Filed against Elanco Animal Health; Investors are Urged to Contact BFA Law before December 6 Court Deadline (NYSE:ELAN)

NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elanco Animal Health Incorporated (NYSE:ELAN) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Elanco, you are encouraged to obtain

ADMA SHAREHOLDER ALERT: ADMA Biologics, Inc. is Under Investigation for Securities Fraud after Auditor Resignation and 20% Stock Drop; Investors are Urged to Contact BFA Law (Nasdaq:ADMA)

NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ: ADMA) for potential violations of the federal securities laws. If you invested in ADMA Biologics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/adma-biologics-inc. Why Did ADMA Biologics’s Stock

ACHC SHAREHOLDER ALERT: Acadia Healthcare Company is Under Investigation for Securities Fraud after 17% Stock Drop; Investors are Urged to Contact BFA Law (Nasdaq:ACHC)

NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Acadia Healthcare Company, Inc. (NASDAQ: ACHC) for potential violations of the federal securities laws. If you invested in Acadia Healthcare, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/acadia-healthcare-company-inc. Why Did Acadia Healthcare’s

Scroll to Top